참고문헌
- Berdyshev, E. V. (2000) Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108, 169-190. https://doi.org/10.1016/S0009-3084(00)00195-X
- Blum, F. C., Chen, C., Kroken, A. R. and Barbieri, J. T. (2012) Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infect. Immun. 80, 1662-1669. https://doi.org/10.1128/IAI.00057-12
- Brazin, K. N., Mallis, R. J., Li, C., Keskin, D. B., Arthanari, H., Gao, Y., Wu, S. L., Karger, B. L., Wagner, G. and Reinherz, E. L. (2014) Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments. J. Biol. Chem. 289, 18880-18892. https://doi.org/10.1074/jbc.M114.574996
- Cutando, L., Busquets-Garcia, A., Puighermanal, E., Gomis-Gonzalez, M., Delgado-Garcia, J. M., Gruart, A., Maldonado, R. and Ozaita, A. (2013) Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J. Clin. Invest. 123, 2816-2831. https://doi.org/10.1172/JCI67569
- Fattore, L. and Fratta, W. (2011) Beyond THC: The new generation of cannabinoid designer drugs. Front. Behav. Neurosci. 5, 60.
- Friedman, H., Newton, C. and Klein, T. W. (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin. Microbiol. Rev. 16, 209-219. https://doi.org/10.1128/CMR.16.2.209-219.2003
- Gagnon, E., Schubert, D. A., Gordo, S., Chu, H. H. and Wucherpfennig, K. W. (2012) Local changes in lipid environment of TCR microclusters regulate membrane binding by the CD3epsilon cytoplasmic domain. J. Exp. Med. 209, 2423-2439. https://doi.org/10.1084/jem.20120790
- Hermanns-Clausen, M., Kneisel, S., Szabo, B. and Auwarter, V. (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108, 534-544. https://doi.org/10.1111/j.1360-0443.2012.04078.x
- Hoffman, A. F., Laaris, N., Kawamura, M., Masino, S. A. and Lupica, C. R. (2010) Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J. Neurosci. 30, 545-555. https://doi.org/10.1523/JNEUROSCI.4920-09.2010
- Hohmann, N., Mikus, G. and Czock, D. (2014) Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals. Dtsch. Arztebl. Int. 111, 139-147.
- Huffman, J. W., Szklennik, P. V., Almond, A., Bushell, K., Selley, D. E., He, H., Cassidy, M. P., Wiley, J. L. and Martin, B. R. (2005a) 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg. Med. Chem. Lett. 15, 4110-4113. https://doi.org/10.1016/j.bmcl.2005.06.008
- Huffman, J. W., Zengin, G., Wu, M. J., Lu, J., Hynd, G., Bushell, K., Thompson, A. L., Bushell, S., Tartal, C., Hurst, D. P., Reggio, P. H., Selley, D. E., Cassidy, M. P., Wiley, J. L. and Martin, B. R. (2005b) Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg. Med. Chem. 13, 89-112. https://doi.org/10.1016/j.bmc.2004.09.050
- Julio-Pieper, M., Flor, P. J., Dinan, T. G. and Cryan, J. F. (2011) Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol. Rev. 63, 35-58. https://doi.org/10.1124/pr.110.004036
- Kerblat, I., Tongiani-Dahshan, S., Aude-Garcia, C., Villiers, M., Drouet, C. and Marche, P. N. (2000) Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes. Immunology 100, 178-184. https://doi.org/10.1046/j.1365-2567.2000.00032.x
- Kim, J. C., Cook, M. N., Carey, M. R., Shen, C., Regehr, W. G. and Dymecki, S. M. (2009) Linking genetically defined neurons to behavior through a broadly applicable silencing allele. Neuron 63, 305-315. https://doi.org/10.1016/j.neuron.2009.07.010
- Kim, K. H., Ha, J. H., Chung, S. H., Kim, C. T., Kim, S. K., Hyun, B. H., Sawada, K., Fukui, Y., Park, I. K., Lee, G. J., Kim, B. K., Lee, N. S. and Jeong, Y. G. (2003) Glutamate and GABA concentrations in the cerebellum of novel ataxic mutant Pogo mice. J. Vet. Sci. 4, 209-212.
- McKallip, R. J., Lombard, C., Fisher, M., Martin, B. R., Ryu, S., Grant, S., Nagarkatti, P. S. and Nagarkatti, M. (2002a) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100, 627-634. https://doi.org/10.1182/blood-2002-01-0098
-
McKallip, R. J., Lombard, C., Martin, B. R., Nagarkatti, M. and Nagarkatti, P. S. (2002b)
${\Delta}^9$ -tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. J. Pharmacol. Exp. Ther. 302, 451-465. https://doi.org/10.1124/jpet.102.033506 - Mocellin, S., Provenzano, M., Rossi, C. R., Pilati, P., Nitti, D. and Lise, M. (2003) Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. J. Immunol. Methods 280, 1-11. https://doi.org/10.1016/S0022-1759(03)00274-6
- Pascual, F. B., McGinley, E. L., Zanardi, L. R., Cortese, M. M. and Murphy, T. V. (2003) Tetanus surveillance--United States, 1998--2000. MMWR Surveill. Summ. 52, 1-8.
- Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M. and Nagarkatti, P. (2010) Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology 215, 598-605. https://doi.org/10.1016/j.imbio.2009.04.001
- Robinson, R. H., Meissler, J. J., Breslow-Deckman, J. M., Gaughan, J., Adler, M. W. and Eisenstein, T. K. (2013) Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction. J. Neuroimmune Pharmacol. 8, 1239-1250. https://doi.org/10.1007/s11481-013-9485-1
- Robinson, R. H., Meissler, J. J., Fan, X., Yu, D., Adler, M. W. and Eisenstein, T. K. (2015) A CB2-selective cannabinoid suppresses T-cell activities and increases tregs and IL-10. J. Neuroimmune Pharmacol. 10, 318-332. https://doi.org/10.1007/s11481-015-9611-3
- Seely, K. A., Prather, P. L., James, L. P. and Moran, J. H. (2011) Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Mol. Interv. 11, 36-51. https://doi.org/10.1124/mi.11.1.6
- Starlets, D., Gore, Y., Binsky, I., Haran, M., Harpaz, N., Shvidel, L., Becker-Herman, S., Berrebi, A. and Shachar, I. (2006) Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107, 4807-4816. https://doi.org/10.1182/blood-2005-11-4334
- Tanaka, Y., Koido, S., Xia, J., Ohana, M., Liu, C., Cote, G. M., Sawyer, D. B., Calderwood, S. and Gong, J. (2004) Development of antigen-specific CD8+ CTL in MHC class I-deficient mice through CD4 to CD8 conversion. J. Immunol. 172, 7848-7858. https://doi.org/10.4049/jimmunol.172.12.7848
- Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman, K. (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978-2986. https://doi.org/10.4049/jimmunol.164.6.2978
- Yamamoto, M., Wada, N., Kitabatake, Y., Watanabe, D., Anzai, M., Yokoyama, M., Teranishi, Y. and Nakanishi, S. (2003) Reversible suppression of glutamatergic neurotransmission of cerebellar granule cells in vivo by genetically manipulated expression of tetanus neurotoxin light chain. J. Neurosci. 23, 6759-6767. https://doi.org/10.1523/JNEUROSCI.23-17-06759.2003
- Yao, B. and Mackie, K. (2009) Endocannabinoid receptor pharmacology. Curr. Top. Behav. Neurosci. 1, 37-63.
- Yeh, F. L., Dong, M., Yao, J., Tepp, W. H., Lin, G., Johnson, E. A. and Chapman, E. R. (2010) SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog. 6, e1001207. https://doi.org/10.1371/journal.ppat.1001207
피인용 문헌
- Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists vol.134, pp.1, 2017, https://doi.org/10.1016/j.neuropharm.2017.10.041
- Designers Drugs—A New Challenge to Emergency Departments—An Observational Study in Poland vol.56, pp.7, 2017, https://doi.org/10.3390/medicina56070354